메뉴 건너뛰기




Volumn 23, Issue 23, 2005, Pages 5334-5346

Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; SCATTER FACTOR; THALIDOMIDE; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

EID: 23944495120     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.723     Document Type: Article
Times cited : (125)

References (48)
  • 1
    • 0037097595 scopus 로고    scopus 로고
    • Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: Therapeutic implications
    • Mitsiades N, Mitsiades CS, Poulaki V, et al: Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: Therapeutic implications. Blood 99:4525-4530, 2002
    • (2002) Blood , vol.99 , pp. 4525-4530
    • Mitsiades, N.1    Mitsiades, C.S.2    Poulaki, V.3
  • 2
    • 0034331194 scopus 로고    scopus 로고
    • Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
    • Hideshima T, Chauhan D, Shima Y, et al: Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood 96:2943-2950, 2000
    • (2000) Blood , vol.96 , pp. 2943-2950
    • Hideshima, T.1    Chauhan, D.2    Shima, Y.3
  • 3
    • 0033168605 scopus 로고    scopus 로고
    • Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha
    • Corral LG, Haslett PA, Muller GW, et al: Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163:380-386, 1999
    • (1999) J Immunol , vol.163 , pp. 380-386
    • Corral, L.G.1    Haslett, P.A.2    Muller, G.W.3
  • 4
    • 0029925419 scopus 로고    scopus 로고
    • Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade
    • Geitz H, Handt S, Zwingenberger K: Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade. Immunopharmacology 31:213-221, 1996
    • (1996) Immunopharmacology , vol.31 , pp. 213-221
    • Geitz, H.1    Handt, S.2    Zwingenberger, K.3
  • 5
    • 0032100486 scopus 로고    scopus 로고
    • Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
    • Haslett PA, Corral LG, Albert M, et al: Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med 187:1885-1892, 1998
    • (1998) J Exp Med , vol.187 , pp. 1885-1892
    • Haslett, P.A.1    Corral, L.G.2    Albert, M.3
  • 6
    • 0035412366 scopus 로고    scopus 로고
    • Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
    • Davies FE, Raje N, Hideshirna T, et al: Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood 98:210-216, 2001
    • (2001) Blood , vol.98 , pp. 210-216
    • Davies, F.E.1    Raje, N.2    Hideshirna, T.3
  • 7
    • 0035186865 scopus 로고    scopus 로고
    • Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxygenase-2
    • Fujita J, Mestre JR, Zeldis JB, et al: Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxygenase-2. Clin Cancer Res 7:3349-3355, 2001
    • (2001) Clin Cancer Res , vol.7 , pp. 3349-3355
    • Fujita, J.1    Mestre, J.R.2    Zeldis, J.B.3
  • 9
    • 0031171663 scopus 로고    scopus 로고
    • Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
    • Kenyon BM, Browne F, D'Amato RJ: Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 64:971-978, 1997
    • (1997) Exp Eye Res , vol.64 , pp. 971-978
    • Kenyon, B.M.1    Browne, F.2    D'Amato, R.J.3
  • 10
    • 0036579909 scopus 로고    scopus 로고
    • Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation
    • Marks MG, Shi J, Fry MO, et al: Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation. Biol Pharm Bull 25: 597-604, 2002
    • (2002) Biol Pharm Bull , vol.25 , pp. 597-604
    • Marks, M.G.1    Shi, J.2    Fry, M.O.3
  • 11
    • 0037262242 scopus 로고    scopus 로고
    • Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis n vivo
    • Lentzsch S, LeBlanc R, Podar K, et al: Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis n vivo. Leukemia 17:41-44, 2003
    • (2003) Leukemia , vol.17 , pp. 41-44
    • Lentzsch, S.1    LeBlanc, R.2    Podar, K.3
  • 12
    • 0041805647 scopus 로고    scopus 로고
    • Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells
    • Li X, Liu X, Wang J, et al: Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells. Anticancer Res 23:2481-2487, 2003
    • (2003) Anticancer Res , vol.23 , pp. 2481-2487
    • Li, X.1    Liu, X.2    Wang, J.3
  • 13
    • 0032748385 scopus 로고    scopus 로고
    • Antitumor activity of thalidomide in refractory multiple myeloma
    • Singhal S, Mehta J, Desikan R, et al: Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341:1565-1571, 1999
    • (1999) N Engl J Med , vol.341 , pp. 1565-1571
    • Singhal, S.1    Mehta, J.2    Desikan, R.3
  • 14
    • 1542608411 scopus 로고    scopus 로고
    • Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma
    • Kumar S, Witzig TE, Dispenzieri A, et al: Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma. Leukemia 18:624-627, 2004
    • (2004) Leukemia , vol.18 , pp. 624-627
    • Kumar, S.1    Witzig, T.E.2    Dispenzieri, A.3
  • 15
    • 0033835945 scopus 로고    scopus 로고
    • Angiogenic factors in multiple myeloma: Higher levels in bone marrow than in peripheral blood
    • Di Raimondo F, Azzaro MP, Palumbo G, et al: Angiogenic factors in multiple myeloma: Higher levels in bone marrow than in peripheral blood. Haematologica 85:800-805, 2000
    • (2000) Haematologica , vol.85 , pp. 800-805
    • Di Raimondo, F.1    Azzaro, M.P.2    Palumbo, G.3
  • 16
    • 2642520461 scopus 로고    scopus 로고
    • Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment
    • Du W, Hattori Y, Hashiguchi A, et al: Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment. Pathol Int 54:285-294, 2004
    • (2004) Pathol Int , vol.54 , pp. 285-294
    • Du, W.1    Hattori, Y.2    Hashiguchi, A.3
  • 17
    • 0142183449 scopus 로고    scopus 로고
    • Endothelial cells in the bone marrow of patients with multiple myeloma
    • Vacca A, Ria R, Semeraro F, et al: Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 102:3340-3348, 2003
    • (2003) Blood , vol.102 , pp. 3340-3348
    • Vacca, A.1    Ria, R.2    Semeraro, F.3
  • 18
    • 0034924216 scopus 로고    scopus 로고
    • Angiogenesis research: Guidelines for translation to clinical application
    • Folkman J, Browder T, Palmblad J: Angiogenesis research: Guidelines for translation to clinical application. Thromb Haemost 86:23-33, 2001
    • (2001) Thromb Haemost , vol.86 , pp. 23-33
    • Folkman, J.1    Browder, T.2    Palmblad, J.3
  • 19
    • 0036797073 scopus 로고    scopus 로고
    • Impact of insulin-like growth factor receptor-1 function on angiogenesis, growth, and metastasis of colon cancer
    • Reinmuth N, Fan F, Liu W, et al: Impact of insulin-like growth factor receptor-1 function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 82:1377-1389, 2002
    • (2002) Lab Invest , vol.82 , pp. 1377-1389
    • Reinmuth, N.1    Fan, F.2    Liu, W.3
  • 20
    • 0344655675 scopus 로고    scopus 로고
    • Insulin-like growth factor binding proteins: New proteins, new functions
    • Ferry RJ, Jr., Cerri RW, Cohen P: Insulin-like growth factor binding proteins: new proteins, new functions. Norm Res 51:53-67, 1999
    • (1999) Norm Res , vol.51 , pp. 53-67
    • Ferry Jr., R.J.1    Cerri, R.W.2    Cohen, P.3
  • 21
    • 2942711726 scopus 로고    scopus 로고
    • Thalidomide: Current role in the treatment of non-plasma cell malignancies
    • Kumar S, Witzig TE, Rajkumar SV: Thalidomide: Current role in the treatment of non-plasma cell malignancies. J Clin Oncol 22: 2477-2488, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 2477-2488
    • Kumar, S.1    Witzig, T.E.2    Rajkumar, S.V.3
  • 22
    • 0034872059 scopus 로고    scopus 로고
    • Management of Kaposi sarcoma: The role of Interferon and thalidomide
    • Krown SE: Management of Kaposi sarcoma: The role of Interferon and thalidomide. Curr Opin Oncol 13:374-381, 2001
    • (2001) Curr Opin Oncol , vol.13 , pp. 374-381
    • Krown, S.E.1
  • 23
    • 0038509089 scopus 로고    scopus 로고
    • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group
    • International Myeloma Working Group
    • International Myeloma Working Group: Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. Br J Haematol 121:749-757, 2003
    • (2003) Br J Haematol , vol.121 , pp. 749-757
  • 24
    • 0022973287 scopus 로고
    • Staging and kinetics of multiple myeloma
    • Durie BG: Staging and kinetics of multiple myeloma. Semin Oncol 13:300-309, 1986
    • (1986) Semin Oncol , vol.13 , pp. 300-309
    • Durie, B.G.1
  • 25
    • 8244221004 scopus 로고    scopus 로고
    • The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line
    • Albini A, Paglieri I, Orengo G, et al: The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 11:713-721, 1997
    • (1997) AIDS , vol.11 , pp. 713-721
    • Albini, A.1    Paglieri, I.2    Orengo, G.3
  • 26
    • 0032100604 scopus 로고    scopus 로고
    • Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent
    • Bauer KS, Dixon SC, Figureg WD: Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent. Biochem Pharmacol 55:1827-1834, 1998
    • (1998) Biochem Pharmacol , vol.55 , pp. 1827-1834
    • Bauer, K.S.1    Dixon, S.C.2    Figureg, W.D.3
  • 27
    • 20944437020 scopus 로고    scopus 로고
    • Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma
    • Mattioli M, Agnelli L, Fabris S, et al: Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma. Oncogene 24:2461-2473, 2005
    • (2005) Oncogene , vol.24 , pp. 2461-2473
    • Mattioli, M.1    Agnelli, L.2    Fabris, S.3
  • 28
    • 0035942271 scopus 로고    scopus 로고
    • Significance analysis of microarrays applied to the ionizing radiation response
    • Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121, 2001
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 5116-5121
    • Tusher, V.G.1    Tibshirani, R.2    Chu, G.3
  • 29
    • 9144271651 scopus 로고    scopus 로고
    • Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-Europe against cancer program
    • Beillard E, Pallisgaard N, van der Velden VH, et al: Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-Europe against cancer program Leukemia 17:2474-2486, 2003
    • (2003) Leukemia , vol.17 , pp. 2474-2486
    • Beillard, E.1    Pallisgaard, N.2    van der Velden, V.H.3
  • 30
    • 0035710746 scopus 로고    scopus 로고
    • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
    • Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408, 2001
    • (2001) Methods , vol.25 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 31
    • 10444265117 scopus 로고    scopus 로고
    • A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endotheiial cells of patients with multiple myeloma
    • Ria R, Vacca A, Russo F, et al: A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endotheiial cells of patients with multiple myeloma. Thromb Haemost 92:1438-1445, 2004
    • (2004) Thromb Haemost , vol.92 , pp. 1438-1445
    • Ria, R.1    Vacca, A.2    Russo, F.3
  • 32
    • 0031017221 scopus 로고    scopus 로고
    • Vascular endotheiial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma
    • Masood R, Cai J, Zheng T, et al: Vascular endotheiial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 94:979-984, 1997
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 979-984
    • Masood, R.1    Cai, J.2    Zheng, T.3
  • 33
    • 9044228402 scopus 로고    scopus 로고
    • Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases
    • Gualandris A, Rusnati M, Belleri M, et al: Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ 7:147-160, 1996
    • (1996) Cell Growth Differ , vol.7 , pp. 147-160
    • Gualandris, A.1    Rusnati, M.2    Belleri, M.3
  • 34
    • 3142767799 scopus 로고    scopus 로고
    • Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas
    • Streubel B, Chott A, Huber D, et al: Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 351:250-259, 2004
    • (2004) N Engl J Med , vol.351 , pp. 250-259
    • Streubel, B.1    Chott, A.2    Huber, D.3
  • 35
    • 0030753430 scopus 로고    scopus 로고
    • Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression
    • Finkenzeller G, Sparacio A, Technau A, et al: Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15:669-676, 1997
    • (1997) Oncogene , vol.15 , pp. 669-676
    • Finkenzeller, G.1    Sparacio, A.2    Technau, A.3
  • 36
    • 2442466643 scopus 로고    scopus 로고
    • Transcriptional regulation of FGF-2 gene expression in cardiac myocytes
    • Jimenez SK, Sheikh F, Jin Y, et al: Transcriptional regulation of FGF-2 gene expression in cardiac myocytes. Cardiovasc Res 62:548-557, 2004
    • (2004) Cardiovasc Res , vol.62 , pp. 548-557
    • Jimenez, S.K.1    Sheikh, F.2    Jin, Y.3
  • 37
    • 0030793394 scopus 로고    scopus 로고
    • Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors
    • Jiang JG, Chen Q, Bell A, et al: Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors. Oncogene 14:3039-3049, 1997
    • (1997) Oncogene , vol.14 , pp. 3039-3049
    • Jiang, J.G.1    Chen, Q.2    Bell, A.3
  • 38
    • 0348011664 scopus 로고    scopus 로고
    • Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells
    • Li T, Chen YH, Liu TJ, et al: Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells. Circ Res 93:1202-1209, 2003
    • (2003) Circ Res , vol.93 , pp. 1202-1209
    • Li, T.1    Chen, Y.H.2    Liu, T.J.3
  • 39
    • 0036386341 scopus 로고    scopus 로고
    • Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: Alteration of the Sp1/Sp3/HDAC1 multiprotem complex
    • Choi HS, Lee JH, Park JG, et al: Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: Alteration of the Sp1/Sp3/HDAC1 multiprotem complex. Biochem Biophys Res Commun 296:1005-1012, 2002
    • (2002) Biochem Biophys Res Commun , vol.296 , pp. 1005-1012
    • Choi, H.S.1    Lee, J.H.2    Park, J.G.3
  • 40
    • 0034929708 scopus 로고    scopus 로고
    • Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer
    • Black AR, Black JD, Azizkhan-Clifford J: Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188:143-160, 2001
    • (2001) J Cell Physiol , vol.188 , pp. 143-160
    • Black, A.R.1    Black, J.D.2    Azizkhan-Clifford, J.3
  • 42
    • 0035137882 scopus 로고    scopus 로고
    • Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kB
    • Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kB. J Clin Invest 107:241-246, 2001
    • (2001) J Clin Invest , vol.107 , pp. 241-246
    • Baldwin, A.S.1
  • 43
    • 0033876198 scopus 로고    scopus 로고
    • Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals
    • Sauer H, Gunther J, Heschler J, et al: Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals. Am J Pathol 156:151-158, 2000
    • (2000) Am J Pathol , vol.156 , pp. 151-158
    • Sauer, H.1    Gunther, J.2    Heschler, J.3
  • 44
    • 0347320849 scopus 로고    scopus 로고
    • A novel hypothesis for thalidomide-induced limb teratogenesis: Redox misregulation of the NF-kappaB pathway
    • Hansen JM, Harris C: A novel hypothesis for thalidomide-induced limb teratogenesis: Redox misregulation of the NF-kappaB pathway. Antioxid Redox Signal 6:1-14, 2004
    • (2004) Antioxid Redox Signal , vol.6 , pp. 1-14
    • Hansen, J.M.1    Harris, C.2
  • 45
    • 0030851721 scopus 로고    scopus 로고
    • Genomic organization of human and mouse genes for vascular endothelial growth factor C
    • Chilov D, Kukk E, Taira S, et al: Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 272:25176-25183, 1997
    • (1997) J Biol Chem , vol.272 , pp. 25176-25183
    • Chilov, D.1    Kukk, E.2    Taira, S.3
  • 46
    • 0028029457 scopus 로고
    • Functions of glutathione and glutathione disulfide in immunology and immunopathology
    • Droge W, Schulze-Osthoff K, Mihm S, et al: Functions of glutathione and glutathione disulfide in immunology and immunopathology FASEB J 8:1131-1138, 1994
    • (1994) FASEB J , vol.8 , pp. 1131-1138
    • Droge, W.1    Schulze-Osthoff, K.2    Mihm, S.3
  • 47
    • 0141449246 scopus 로고    scopus 로고
    • Treatment of relapsed and refractory multiple myeloma
    • Singhal S, Mehta J: Treatment of relapsed and refractory multiple myeloma. Curr Treat Options Oncol 4:229-237, 2003
    • (2003) Curr Treat Options Oncol , vol.4 , pp. 229-237
    • Singhal, S.1    Mehta, J.2
  • 48
    • 0347383743 scopus 로고    scopus 로고
    • Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease
    • Rajkumar SV: Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease. Semin Hematol 40:17-22, 2003
    • (2003) Semin Hematol , vol.40 , pp. 17-22
    • Rajkumar, S.V.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.